|
Real-time Estimate
Cboe BZX
14:45:54 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 13.76 USD | +0.11% |
|
+0.15% | +92.05% |
| 10-22 | India's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say | RE |
| 10-19 | India new issue - Sun Pharma to issue over five-year bonds, bankers say | RE |
| Market Cap | 3.61B 3.24B 3B 2.71B 5.07B 344B 5.13B 35.81B 14.26B 180B 13.55B 13.26B 571B | P/E 2026 * |
6.14x | P/E 2027 * | 5.17x |
|---|---|---|---|---|---|
| Enterprise Value | 10.66B 9.57B 8.85B 8.01B 14.97B 1,016B 15.15B 106B 42.13B 531B 40.02B 39.17B 1,687B | EV / Sales 2026 * |
1.73x | EV / Sales 2027 * | 1.56x |
| Free-Float |
99.54% | Yield 2026 * |
0.58% | Yield 2027 * | 0.58% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| OGN | Delayed | |
CBOE
| OGN | Real-time | |
|
Tradegate
| 7XP | Real-time | |
|
Boerse Muenchen
| 7XP | Real-time | |
|
Borsa Italiana
| 1OGN | End-of-day quote | |
|
London S.E.
| 0A9W | Delayed | |
|
Mexican S.E.
| OGN * | End-of-day quote | |
|
Börse Stuttgart
| 7XP | Delayed | |
|
Deutsche Boerse AG
| 7XP | Delayed |
Last Transcript: Organon & Co.
| 1 day | +0.11% | ||
| 1 week | +0.15% | ||
| Current month | +0.51% | ||
| 1 month | +0.29% | ||
| 3 months | +1.85% | ||
| 6 months | +3.38% | ||
| Current year | +92.05% |
| 1 week | 13.74 |  | 13.78 |
| 1 month | 13.7 | | 13.83 |
| Current year | 5.69 | | 13.83 |
| 1 year | 5.69 | | 13.83 |
| 3 years | 5.69 | | 23.1 |
| 5 years | 5.69 | | 39.48 |
| 10 years | 5.69 | | 39.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Morrissey
CEO | Chief Executive Officer | 61 | 2025-10-25 |
Matthew Walsh
DFI | Director of Finance/CFO | 59 | 2021-06-01 |
Susan O'Neal
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Carrie Cox
CHM | Chairman | 68 | 2021-06-01 |
Robert Essner
BRD | Director/Board Member | 78 | 2021-06-01 |
| Director/Board Member | 72 | 2021-06-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/11/26 | Exercice | Chief Technology Officer | 27,172 | 0.0103% | ||
| 8/5/26 | Sell | Head of Mfg & Supply | -14,761 | 0.0056% | ||
| 6/12/26 | Free | Director | 17,857 | 0.0068% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +0.15% | +106.76% | -7.77% | 3.61B | |
| +0.74% | +1.36% | +57.06% | +127.68% | 1,143B | |
| +0.91% | +5.37% | +45.31% | +84.74% | 647B | |
| +0.15% | +1.01% | +26.43% | +102.74% | 506B | |
| -0.05% | +1.73% | +52.74% | +65.27% | 384B | |
| -1.00% | -6.29% | +61.39% | +36.79% | 350B | |
| +0.34% | +1.84% | +30.70% | +52.69% | 293B | |
| -0.45% | +1.19% | +2.89% | +24.92% | 265B | |
| +0.48% | +2.89% | +54.40% | +71.36% | 242B | |
| -0.23% | +3.79% | +35.22% | +104.96% | 197B | |
| Average | +0.09% | +0.75% | +47.29% | +66.34% | 403.11B | |
| Weighted average by Cap. | +0.25% | +0.71% | +44.63% | +87.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.16B 5.52B 5.11B 4.63B 8.64B 586B 8.75B 61.07B 24.32B 307B 23.11B 22.62B 974B | 6.29B 5.64B 5.21B 4.72B 8.82B 599B 8.93B 62.34B 24.83B 313B 23.59B 23.09B 994B |
| Net income | 601M 539M 499M 452M 844M 57.24B 854M 5.96B 2.37B 29.95B 2.26B 2.21B 95.09B | 721M 647M 598M 542M 1.01B 68.67B 1.02B 7.15B 2.85B 35.93B 2.71B 2.65B 114B |
| Net Debt | 7.05B 6.33B 5.85B 5.3B 9.9B 672B 10.02B 69.95B 27.86B 352B 26.47B 25.91B 1,116B | 6.17B 5.54B 5.12B 4.64B 8.67B 588B 8.77B 61.24B 24.39B 308B 23.17B 22.68B 977B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | US$13.77 | +0.11% | 2,139,458 |
| 26-10-27 | US$13.75 | +0.07% | 1,865,054 |
| 26-10-26 | US$13.74 | -0.07% | 1,548,458 |
| 26-10-23 | US$13.75 | 0.00% | 1,054,002 |
| 26-10-22 | US$13.75 | 0.00% | 2,553,568 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OGN Stock
Select your edition
All financial news and data tailored to specific country editions
